Glycosylated haemoglobin as an indicator of diabetes control in pregnancy: A 10-year review of the relationship between HbA1c trends and delivery outcome in type I and type II diabetes.

MLA

Finnegan, Catherine, et al. “Glycosylated Haemoglobin as an Indicator of Diabetes Control in Pregnancy: A 10-Year Review of the Relationship between HbA1c Trends and Delivery Outcome in Type I and Type II Diabetes.” European Journal of Obstetrics, Gynecology, and Reproductive Biology, vol. 281, Feb. 2023, pp. 36–40. EBSCOhost, https://doi.org/10.1016/j.ejogrb.2022.12.007.

APA

Finnegan, C., Smyth, S., Smith, O., Dicker, P., & Breathnach, F. M. (2023). Glycosylated haemoglobin as an indicator of diabetes control in pregnancy: A 10-year review of the relationship between HbA1c trends and delivery outcome in type I and type II diabetes. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 281, 36–40. https://doi.org/10.1016/j.ejogrb.2022.12.007

Chicago

Finnegan, Catherine, Suzanne Smyth, Orla Smith, Patrick Dicker, and Fionnuala M Breathnach. 2023. “Glycosylated Haemoglobin as an Indicator of Diabetes Control in Pregnancy: A 10-Year Review of the Relationship between HbA1c Trends and Delivery Outcome in Type I and Type II Diabetes.” European Journal of Obstetrics, Gynecology, and Reproductive Biology 281 (February): 36–40. doi:10.1016/j.ejogrb.2022.12.007.